mirvetuximab
ImmunoGen
['mirvetuximab', 'ovarian', 'thanks']
practice-changing results: 1st phase 3 trial to show improvement in overall survival in platinum-resistant ovarian cancer (proc). mirvetuximab-setting a new standard of care for women with fr+ proc. thanks to all patients and researchers #asco23 
Consultant Medical Oncologist, Royal Marsden, Team Leader ICR All views my own